- ASSISTANT PROFESSOR | Ophthalmology
- Hospital Affiliations
- New York Eye and Ear Infirmary of Mount Sinai
- The Mount Sinai Hospital
- Mount Sinai St. Luke's and Mount Sinai West
Nisha Chadha, MD is a board-certified ophthalmologist, specializing in cataracts and glaucoma, at Mount Sinai Doctors, seeing patients on Thursdays in Brooklyn Heights. Trained in Washington, DC, and New Haven, she is certified by the American Board of Ophthalmology and a member of the American Academy of Ophthalmology and the American Glaucoma Society. She was awarded her medical degree from George Washington University and completed her residency in Ophthalmology at George Washington University and fellowship in Glaucoma at the Yale Medical Center. She has a particular interest in medical and surgical management of glaucoma and received training in both traditional and minimally invasive glaucoma surgical (MIGS) procedures. Dr. Chadha also serves as a representative for the EyeCare America Foundation. Her research interests include MIGS, laser therapies for glaucoma, and medical education.
MD, George Washington University
Internship, Internal Medicine
Washington Hospital Center
George Washington University Hosp.
Yale Medical Center
Sun X, Xu CS, Chadha N, Chen A, Liu J. Marijuana for Glaucoma: A Recipe for Disaster or Treatment? Yale J Biol Med. 2015;88(3):265-9. .;.
Chadha N, Liu J, Teng CC. Resident and Fellow Glaucoma Surgical Experience Following the Tube Versus Trabeculectomy Study. Ophthalmology. 2015;122(9):1953-4. .;.
Rajjoub LZ, Chadha N, Belyea DA. Intermittent acute angle closure glaucoma and chronic angle closure following topiramate use with plateau iris configuration. Clin Ophthalmol. 2014;8:1351-4..;.
Chadha N, Lamba T, Belyea DA, Merchant KY. Indirect cyclopexy for treatment of a chronic traumatic cyclodialysis cleft with hypotony. Clin Ophthalmol. 2014;8:591-4..;.
Tanna N, Chadha N, Sharma RR, Goodman JF, Sadeghi N. Malignant ossifying fibromyxoid tumor of the parapharyngeal space. Ear Nose Throat J. 2012;91(10):E15-7..;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Chadha did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.